HSBC Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.27M | Sell |
19,700
-20,700
| -51% | -$4.59M | ﹤0.01% | 1218 |
|
|
2025
Q4 | $9.26M | Buy |
40,400
+17,400
| +76% | +$3.96M | ﹤0.01% | 984 |
|
|
2025
Q3 | $5.27M | Hold |
23,000
| – | – | ﹤0.01% | 1163 |
|
|
2025
Q2 | $4.25M | Sell |
23,000
-22,600
| -50% | -$4.2M | ﹤0.01% | 1217 |
|
|
2025
Q1 | $9.45M | Buy |
45,600
+16,500
| +57% | +$3.21M | 0.01% | 910 |
|
|
2024
Q4 | $5.14M | Sell |
29,100
-3,300
| -10% | -$607K | ﹤0.01% | 1125 |
|
|
2024
Q3 | $6.34M | Buy |
32,400
+6,800
| +27% | +$1.27M | ﹤0.01% | 1043 |
|
|
2024
Q2 | $4.35M | Sell |
25,600
-17,400
| -40% | -$2.88M | ﹤0.01% | 1100 |
|
|
2024
Q1 | $7.83M | Sell |
43,000
-6,900
| -14% | -$1.19M | 0.01% | 968 |
|
|
2023
Q4 | $7.71M | Hold |
49,900
| – | – | 0.01% | 990 |
|
|
2023
Q3 | $7.45M | Buy |
49,900
+200
| +0.4% | +$29.4K | 0.01% | 942 |
|
|
2023
Q2 | $6.7M | Sell |
49,700
-35,300
| -42% | -$5.18M | 0.01% | 947 |
|
|
2023
Q1 | $13.5M | Sell |
85,000
-33,500
| -28% | -$5.12M | 0.02% | 741 |
|
|
2022
Q4 | $19M | Buy |
118,500
+65,500
| +124% | +$10M | 0.02% | 677 |
|
|
2022
Q3 | $7.25M | Sell |
53,000
-25,600
| -33% | -$3.67M | 0.01% | 1030 |
|
|
2022
Q2 | $12.1M | Buy |
78,600
+10,400
| +15% | +$1.59M | 0.02% | 798 |
|
|
2022
Q1 | $11.2M | Buy |
68,200
+38,000
| +126% | +$5.52M | 0.01% | 839 |
|
|
2021
Q4 | $4.1M | Sell |
30,200
-4,000
| -12% | -$473K | ﹤0.01% | 1355 |
|
|
2021
Q3 | $3.72M | Buy |
34,200
+33,300
| +3,700% | +$3.81M | ﹤0.01% | 1283 |
|
|
2021
Q2 | $101K | Sell |
900
-39,900
| -98% | -$4.49M | ﹤0.01% | 2847 |
|
|
2021
Q1 | $4.44M | Sell |
40,800
-14,200
| -26% | -$1.52M | 0.01% | 1068 |
|
|
2020
Q4 | $5.84M | Sell |
55,000
-21,700
| -28% | -$2.09M | 0.01% | 963 |
|
|
2020
Q3 | $6.75M | Buy |
+76,700
| New | +$7.22M | 0.01% | 842 |
|
|
2020
Q2 | – | Sell |
-154,000
| Closed | -$11.8M | – | 2628 |
|
|
2020
Q1 | $11.8M | Sell |
154,000
-178,400
| -54% | -$15.2M | 0.03% | 517 |
|
|
2019
Q4 | $29.2M | Buy |
332,400
+41,300
| +14% | +$3.43M | 0.05% | 379 |
|
|
2019
Q3 | $22M | Buy |
291,100
+112,600
| +63% | +$7.72M | 0.04% | 495 |
|
|
2019
Q2 | $13M | Sell |
178,500
-117,500
| -40% | -$9.24M | 0.02% | 701 |
|
|
2019
Q1 | $23.9M | Buy |
296,000
+122,600
| +71% | +$10M | 0.04% | 447 |
|
|
2018
Q4 | $16M | Buy |
173,400
+101,000
| +140% | +$8.88M | 0.03% | 595 |
|
|
2018
Q3 | $6.85M | Buy |
72,400
+26,800
| +59% | +$2.54M | 0.01% | 1006 |
|
|
2018
Q2 | $4.22M | Sell |
45,600
-145,000
| -76% | -$14.2M | 0.01% | 1193 |
|
|
2018
Q1 | $18M | Buy |
+190,600
| New | +$20.9M | 0.03% | 589 |
|
|
2017
Q4 | – | Sell |
-237,300
| Closed | -$21.1M | – | 2021 |
|
|
2017
Q3 | $21.1M | Buy |
237,300
+19,900
| +9% | +$1.51M | 0.03% | 520 |
|
|
2017
Q2 | $15.8M | Sell |
217,400
-141,500
| -39% | -$9.51M | 0.03% | 586 |
|
|
2017
Q1 | $23.4M | Sell |
358,900
-136,200
| -28% | -$8.56M | 0.05% | 434 |
|
|
2016
Q4 | $31M | Buy |
495,100
+279,500
| +130% | +$17.1M | 0.07% | 322 |
|
|
2016
Q3 | $13.6M | Sell |
215,600
-27,500
| -11% | -$1.78M | 0.03% | 557 |
|
|
2016
Q2 | $15.1M | Buy |
243,100
+88,000
| +57% | +$5.36M | 0.04% | 514 |
|
|
2016
Q1 | $8.86M | Sell |
155,100
-70,100
| -31% | -$3.91M | 0.03% | 699 |
|
|
2015
Q4 | $13.3M | Buy |
+225,200
| New | +$13M | 0.03% | 578 |
|
|
2015
Q3 | – | Sell |
-176,600
| Closed | -$11.9M | – | 1924 |
|
|
2015
Q2 | $11.9M | Buy |
176,600
+159,900
| +957% | +$10.4M | 0.02% | 579 |
|
|
2015
Q1 | $978K | Buy |
16,700
+6,400
| +62% | +$387K | ﹤0.01% | 1360 |
|
|
2014
Q4 | $674K | Hold |
10,300
| – | – | ﹤0.01% | 1415 |
|
|
2014
Q3 | $595K | Buy |
10,300
+7,400
| +255% | +$411K | ﹤0.01% | 1432 |
|
|
2014
Q2 | $164K | Hold |
2,900
| – | – | ﹤0.01% | 1707 |
|
|
2014
Q1 | $149K | Buy |
+2,900
| New | +$147K | ﹤0.01% | 1669 |
|
Other funds holding ABBV
VCM
VPM
HSBC Holdings's ABBV Position: Q1 2026 in Review
HSBC Holdings reduced its AbbVie (ABBV) stake by 5% in Q1 2026, selling an estimated $45.4M and leaving 3,860,492 shares worth $839M. The position accounts for 0.44% of the portfolio, ranked #34.
HSBC Holdings first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $930M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- HSBC Holdings held 3,860,492 shares of AbbVie worth $839M as of Q1 2026.
- HSBC Holdings sold 204,488 AbbVie shares in Q1 2026, an estimated $45.4M.
- AbbVie made up 0.44% of HSBC Holdings's portfolio in Q1 2026, its #34 holding.
- HSBC Holdings first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's AbbVie position peaked at $930M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.